JPMorgan Chase & Co’s Myovant Sciences Ltd. MYOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-53,492
Closed -$1.44M 6315
2022
Q4
$1.44M Sell
53,492
-134,022
-71% -$3.61M ﹤0.01% 3170
2022
Q3
$3.37M Sell
187,514
-46,877
-20% -$842K ﹤0.01% 2593
2022
Q2
$2.91M Buy
234,391
+218,733
+1,397% +$2.72M ﹤0.01% 2769
2022
Q1
$208K Buy
15,658
+830
+6% +$11K ﹤0.01% 4427
2021
Q4
$230K Buy
14,828
+1,360
+10% +$21.1K ﹤0.01% 4466
2021
Q3
$302K Buy
13,468
+312
+2% +$7K ﹤0.01% 4212
2021
Q2
$299K Buy
13,156
+860
+7% +$19.5K ﹤0.01% 4285
2021
Q1
$253K Buy
12,296
+9,140
+290% +$188K ﹤0.01% 4368
2020
Q4
$87K Buy
3,156
+461
+17% +$12.7K ﹤0.01% 4339
2020
Q3
$42K Sell
2,695
-393
-13% -$6.13K ﹤0.01% 4337
2020
Q2
$63K Sell
3,088
-1,308
-30% -$26.7K ﹤0.01% 4133
2020
Q1
$34K Sell
4,396
-2,011
-31% -$15.6K ﹤0.01% 4243
2019
Q4
$99K Sell
6,407
-249,170
-97% -$3.85M ﹤0.01% 4031
2019
Q3
$1.33M Buy
255,577
+143,216
+127% +$745K ﹤0.01% 2931
2019
Q2
$1.04M Buy
112,361
+28,941
+35% +$268K ﹤0.01% 3047
2019
Q1
$1.99M Sell
83,420
-38,444
-32% -$918K ﹤0.01% 2643
2018
Q4
$2M Buy
121,864
+30,269
+33% +$497K ﹤0.01% 2646
2018
Q3
$2.43M Sell
91,595
-32,068
-26% -$851K ﹤0.01% 2675
2018
Q2
$2.83M Buy
123,663
+16,719
+16% +$382K ﹤0.01% 2604
2018
Q1
$2.28M Buy
106,944
+6,263
+6% +$133K ﹤0.01% 2676
2017
Q4
$1.27M Buy
100,681
+9,468
+10% +$120K ﹤0.01% 2944
2017
Q3
$1.38M Buy
91,213
+14,203
+18% +$215K ﹤0.01% 2787
2017
Q2
$901K Sell
77,010
-6,060
-7% -$70.9K ﹤0.01% 2948
2017
Q1
$975K Buy
83,070
+19,474
+31% +$229K ﹤0.01% 2914
2016
Q4
$791K Buy
+63,596
New +$791K ﹤0.01% 3080